Array BioPharma (ARRY)
Add to Watchlists Create an AlertArray BioPharma News
Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript)
Seeking Alpha May 21Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript)
Array BioPharma's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)
Seeking Alpha May 16Array BioPharma's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)
10 ASCO '13 Abstracts You Can Read Right Now
May 15Get a head start on searching through ASCO abstracts with these 10 summaries.
Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
PR Newswire May 15BOULDER, Colo., May 15, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, MEK162 (licensed to Novartis) and selumetinib (licensed to AstraZeneca) ...
5 Biotechnology Stocks to Buy Now
Investor Place May 15Five Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
5 Biotechnology Stocks to Buy Now
Investor Place May 8This week, five Biotechnology stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference
PR Newswire May 8BOULDER, Colo., May 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare ...
Array BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Seeking Alpha May 7Array BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ARRY | 5.56 | -0.24 | -4.14% | 649.27M |
